Literature DB >> 24225488

Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.

Talakad G Lohith1, Sami S Zoghbi2, Cheryl L Morse2, Maria D Ferraris Araneta2, Vanessa N Barth3, Nancy A Goebl3, Johannes T Tauscher3, Victor W Pike2, Robert B Innis4, Masahiro Fujita2.   

Abstract

[(11)C]NOP-1A is a novel high-affinity PET ligand for imaging nociceptin/orphanin FQ peptide (NOP) receptors. Here, we report reproducibility and reliability measures of binding parameter estimates for [(11)C]NOP-1A binding in the brain of healthy humans. After intravenous injection of [(11)C]NOP-1A, PET scans were conducted twice on eleven healthy volunteers on the same (10/11 subjects) or different (1/11 subjects) days. Subjects underwent serial sampling of radial arterial blood to measure parent radioligand concentrations. Distribution volume (VT; a measure of receptor density) was determined by compartmental (one- and two-tissue) modeling in large regions and by simpler regression methods (graphical Logan and bilinear MA1) in both large regions and voxel data. Retest variability and intraclass correlation coefficient (ICC) of VT were determined as measures of reproducibility and reliability respectively. Regional [(11)C]NOP-1A uptake in the brain was high, with a peak radioactivity concentration of 4-7 SUV (standardized uptake value) and a rank order of putamen>cingulate cortex>cerebellum. Brain time-activity curves fitted well in 10 of 11 subjects by unconstrained two-tissue compartmental model. The retest variability of VT was moderately good across brain regions except cerebellum, and was similar across different modeling methods, averaging 12% for large regions and 14% for voxel-based methods. The retest reliability of VT was also moderately good in most brain regions, except thalamus and cerebellum, and was similar across different modeling methods averaging 0.46 for large regions and 0.48 for voxels having gray matter probability >20%. The lowest retest variability and highest retest reliability of VT were achieved by compartmental modeling for large regions, and by the parametric Logan method for voxel-based methods. Moderately good reproducibility and reliability measures of VT for [(11)C]NOP-1A make it a useful PET ligand for comparing NOP receptor binding between different subject groups or under different conditions in the same subject.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  AUC; BSMSS; ICC; NOP; NOP receptors; Nociceptin; PET; Test–retest imaging; V(T); WSMSS; area-under-the-curve; between-subject mean sum of squares; f(P); intraclass correlation coefficient; nociceptin/orphanin FQ peptide; plasma free fraction; positron emission tomography; retest variability; total distribution volume; within-subject mean sum of squares

Mesh:

Substances:

Year:  2013        PMID: 24225488      PMCID: PMC3928240          DOI: 10.1016/j.neuroimage.2013.10.068

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  24 in total

1.  Modelling: when and why?

Authors:  M Laruelle
Journal:  Eur J Nucl Med       Date:  1999-06

2.  Effects of statistical noise on graphic analysis of PET neuroreceptor studies.

Authors:  M Slifstein; M Laruelle
Journal:  J Nucl Med       Date:  2000-12       Impact factor: 10.057

Review 3.  Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers.

Authors:  M Slifstein; M Laruelle
Journal:  Nucl Med Biol       Date:  2001-07       Impact factor: 2.408

4.  Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.

Authors:  Yasuyuki Kimura; Masahiro Fujita; Jinsoo Hong; Talakad G Lohith; Robert L Gladding; Sami S Zoghbi; Johannes A Tauscher; Nancy Goebl; Karen S Rash; Zhaogen Chen; Concepcion Pedregal; Vanessa N Barth; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2011-08-30       Impact factor: 10.057

5.  Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.

Authors:  M S Gandelman; R M Baldwin; S S Zoghbi; Y Zea-Ponce; R B Innis
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

6.  No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia.

Authors:  A Abi-Dargham; M Laruelle; J Krystal; C D'Souza; S Zoghbi; R M Baldwin; J Seibyl; O Mawlawi; G de Erasquin; D Charney; R B Innis
Journal:  Neuropsychopharmacology       Date:  1999-06       Impact factor: 7.853

7.  Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder.

Authors:  Paolo Zanotti-Fregonara; Christina S Hines; Sami S Zoghbi; Jeih-San Liow; Yi Zhang; Victor W Pike; Wayne C Drevets; Alan G Mallinger; Carlos A Zarate; Masahiro Fujita; Robert B Innis
Journal:  Neuroimage       Date:  2012-08-10       Impact factor: 6.556

8.  Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand.

Authors:  Garth E Terry; Jeih-San Liow; Sami S Zoghbi; Jussi Hirvonen; Amanda G Farris; Alicja Lerner; Johannes T Tauscher; John M Schaus; Lee Phebus; Christian C Felder; Cheryl L Morse; Jinsoo S Hong; Victor W Pike; Christer Halldin; Robert B Innis
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

9.  Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects.

Authors:  Aurelija Jučaite; Zsolt Cselényi; Annie Arvidsson; Gabrielle Ahlberg; Per Julin; Katarina Varnäs; Per Stenkrona; Jan Andersson; Christer Halldin; Lars Farde
Journal:  EJNMMI Res       Date:  2012-04-23       Impact factor: 3.138

10.  Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.

Authors:  G Delaney; K L Dawe; R Hogan; T Hunjan; J Roper; G Hazell; S J Lolait; A J Fulford
Journal:  J Neuroendocrinol       Date:  2012-12       Impact factor: 3.627

View more
  14 in total

Review 1.  Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

Authors:  Nurulain T Zaveri
Journal:  J Med Chem       Date:  2016-03-14       Impact factor: 7.446

Review 2.  Nociceptin and the nociceptin receptor in learning and memory.

Authors:  Raül Andero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

3.  Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Roberto Ciccocioppo; Brian Lopresti; Jennifer Paris; Michael L Himes; N Scott Mason
Journal:  Biol Psychiatry       Date:  2017-05-31       Impact factor: 13.382

4.  Improved models for plasma radiometabolite correction and their impact on kinetic quantification in PET studies.

Authors:  Matteo Tonietto; Mattia Veronese; Gaia Rizzo; Paolo Zanotti-Fregonara; Talakad G Lohith; Masahiro Fujita; Sami S Zoghbi; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-15       Impact factor: 6.200

Review 5.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  Decreased Nociceptin Receptors Are Related to Resilience and Recovery in College Women Who Have Experienced Sexual Violence: Therapeutic Implications for Posttraumatic Stress Disorder.

Authors:  Rajesh Narendran; Savannah Tollefson; Kelli Fasenmyer; Jennifer Paris; Michael L Himes; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Biol Psychiatry       Date:  2019-04-04       Impact factor: 13.382

Review 7.  Corticotropin releasing hormone and imaging, rethinking the stress axis.

Authors:  Carlo Contoreggi
Journal:  Nucl Med Biol       Date:  2014-11-26       Impact factor: 2.408

8.  Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Savannah Tollefson; Michael L Himes; Jennifer Paris; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Am J Psychiatry       Date:  2019-05-06       Impact factor: 18.112

9.  Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.

Authors:  Andre Der-Avakian; Manoranjan S D'Souza; David N Potter; Elena H Chartoff; William A Carlezon; Diego A Pizzagalli; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2017-03-09       Impact factor: 4.530

10.  Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.

Authors:  Mattia Veronese; Paolo Zanotti-Fregonara; Gaia Rizzo; Alessandra Bertoldo; Robert B Innis; Federico E Turkheimer
Journal:  Neuroimage       Date:  2016-02-02       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.